Journal article
Investigation of the international comparability of population-based routine hospital data set derived comorbidity scores for patients with lung cancer
M Lüchtenborg, EJA Morris, D Tataru, VH Coupland, A Smith, RL Milne, L Te Marvelde, D Baker, J Young, D Turner, D Nishri, C Earle, L Shack, A Gavin, D Fitzpatrick, C Donnelly, Y Lin, B Møller, DH Brewster, A Deas Show all
Thorax | BMJ PUBLISHING GROUP | Published : 2018
Abstract
Introduction The International Cancer Benchmarking Partnership (ICBP) identified significant international differences in lung cancer survival. Differing levels of comorbid disease across ICBP countries has been suggested as a potential explanation of this variation but, to date, no studies have quantified its impact. This study investigated whether comparable, robust comorbidity scores can be derived from the different routine population-based cancer data sets available in the ICBP jurisdictions and, if so, use them to quantify international variation in comorbidity and determine its influence on outcome. Methods Linked population-based lung cancer registry and hospital discharge data sets ..
View full abstractGrants
Funding Acknowledgements
This study was supported primarily by NHS England, with additional contributions from Cancer Control Alberta, Cancer Institute NSW, Norwegian Directorate of Health, Cancer Care Ontario, Scottish Government, Cancer Council Victoria, Public Health Wales, Tenovus Cancer Care, Northern Ireland Cancer Registry, the Public Health Agency for Northern Ireland and the Danish Cancer Society.